CXCL13 and neoplasm: In our study, we observed a slight increase in the expression of IL-17A, IL-6, and CXCL13 following PD-1 signaling activation, and no inhibitory effect on IFN-γ and TNF-α, which are downregulated in tumor T cells [65,66].